Not Found Therapeutic Properties Of Shark Cartilage In The Treatment Of Lung Cancer.
A medicament derived from shark cartilage failed to renovate survival in patients with advanced lung cancer, researchers report. The insufficient results, which came in the finishing stage of testing, showed that the drug didn't help extend the life spans of patients with inoperable platform 3 non-small cell lung cancer. Scientists have been testing drugs derived from shark cartilage because it appears to debar blood vessels from growing around tumors natural-breast-success.club. The anticipate is that the drugs will prevent cancer cells from being fed by blood, which allows them to grow.
Researchers led by Dr Charles Lu, of the University of Texas MD Anderson Cancer Center, tested the delineated dull in question, known as AE-941, on patients in the United States and Canada herpes. In the study, published online May 26 in the Journal of the National Cancer Institute, a compute of 379 patients with inoperable non-small chamber lung cancer were treated with chemoradiotherapy and either AE-941 or an slothful placebo.
There was no significant difference in outcome between the two groups in terms of overall survival, or in stretch of time before the disease progressed, the researchers found. The study authors noted that the study's energy was "the widespread use of poorly regulated complementary and alternative medicine products, such as shark cartilage-derived agents, among patients with advanced cancer, a population likely to be vulnerable to unsubstantiated marketing claims".
Lung cancer also called as bronchogenic carcinoma. Lung cancer is one of the most average cancers in the world. It is a influential cause of cancer death in men and women in the United States. Cigarette smoking causes most lung cancers. The more cigarettes you smoke per epoch and the earlier you started smoking, the greater your hazard of lung cancer. High levels of pollution, diffusion and asbestos exposure may also increase risk.